Clinical Trials Logo

Filter by:
NCT ID: NCT01302847 Completed - HIV Infections Clinical Trials

Safety of and Immune Response to Dolutegravir in HIV-1 Infected Infants, Children, and Adolescents

Start date: April 20, 2011
Phase: Phase 1/Phase 2
Study type: Interventional

Dolutegravir (DTG) is an HIV drug in the integrase inhibitor drug class. This study evaluated the pharmacokinetics (PK), safety, tolerability of and immune response to DTG when used concurrently with optimized background therapy (OBT) in HIV-1 infected infants, children, and adolescents.

NCT ID: NCT01300910 Completed - Circumcision, Male Clinical Trials

Comparison of the Shang Ring With Conventional Surgical Methods

Start date: February 2011
Phase: Phase 2/Phase 3
Study type: Interventional

This is a randomized control trial of 400 adult male circumcision procedures with a one to one ratio between Shang Ring and the in-country standard surgical technique (forceps guided in Kenya and dorsal slit in Zambia).

NCT ID: NCT01298596 Completed - Clinical trials for Cervical Intraepithelial Neoplasia

Cryotherapy vs. LEEP to Treat Cervical Intraepithelial Neoplasia (CIN) 2/3 Among HIV-positive Women

PHE-LEEP
Start date: June 2011
Phase: N/A
Study type: Interventional

The purpose of this study is to compare the rate of recurrence of cervical intraepithelial neoplasia among HIV-positive women receiving cryotherapy versus LEEP over 2 years of follow-up and to compare the shedding of HIV-1 from the cervix between HIV-positive women receiving cryotherapy versus LEEP over 3 weeks of follow-up.

NCT ID: NCT01267942 Completed - Clinical trials for Adenotonsillar Hypertrophy,Under 12 Years.

Intravenous Enhancin[Co-amoxiclav] Versus Postoperative Enhancin in Prevention of Postadenotonsillectomy Morbidity.

Start date: May 2008
Phase: N/A
Study type: Interventional

Null hypothesis; The efficacy of Enhancin]Co-Amoxiclav given as a single intravenous dose at induction is not better than a five days oral course of the same given postoperatively in reducing postoperative morbidity after adenotonsillectomy.

NCT ID: NCT01264445 Completed - HIV Infections Clinical Trials

Safety and Immunogenicity Study of 2 Investigational Preventive HIV Vaccines

Start date: February 2011
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the safety, tolerability, and immunogenicity of an adjuvanted GSK investigational HIV vaccine and Ad35-GRIN in 4 different regimens at months 1, 2, 3, and 4.

NCT ID: NCT01260727 Completed - HIV Infections Clinical Trials

Evaluating the Safety of and Immune Response to an HIV Vaccine Followed by Booster, Administered by Two Devices, in HIV-Uninfected Adults

Start date: February 2010
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the safety of and immune response to an HIV vaccine, administered using two different devices, followed by a vaccine boost, in healthy, HIV-uninfected adults.

NCT ID: NCT01247844 Completed - Male Circumcision Clinical Trials

Evaluation of Healing at Three Time Intervals and Potential for Spontaneous Detachment

Start date: September 2010
Phase: N/A
Study type: Interventional

The objective of this research study is to evaluate the safety and acceptability of the Shang Ring method of medical male circumcision. The Shang Ring is a new circumcision device with a potential role in the safe and cost-effective delivery of circumcision services. The device, developed in China, consists of two concentric plastic rings. Following a ring penile block, the smaller ring is fitted at the base of the coronal sulcus. The foreskin is everted over the inner ring and the larger outer ring is secured over the inner ring. The foreskin is excised and several nicks are made on the incision line to prevent formation of a constricting, circumferential scab. No suturing is required. In this study, the investigators will evaluate wound healing of men randomized to removal of the Shang Ring at one of three different points in time (Days 7, 14 or 21). Leaving the device on for 14 or 21 days constitutes extended wear of the device. Sites: Homa Bay District Hospital, Nyanza Province, Kenya

NCT ID: NCT01243138 Completed - Obesity Clinical Trials

Africa and Middle East Cardiovascular Epidemiological Study

ACE
Start date: July 2011
Phase:
Study type: Observational

This is a cross-sectional, epidemiological study to determine the prevalence of cardiovascular risk factors such as obesity, smoking, dyslipidemia, diabetes mellitus and hypertension in patients attending General Practice clinics in the Africa and Middle East region. A total of 4300 patients will be evaluated. In patients who are found to have previously been diagnosed with cardiovascular (CV) risk factors such as dyslipidemia or hypertension, the level of control of their respective conditions will also be evaluated.

NCT ID: NCT01230814 Completed - Bacterial Vaginosis Clinical Trials

Topical Metronidazole and Miconazole Co-formulated Vaginal Suppositories for Preventing Vaginal Infections in HIV-seronegative Women

Start date: April 2011
Phase: Phase 2
Study type: Interventional

This research study is about vaginal infections such as bacterial vaginosis, yeast infections, and trichomoniasis. Usually, these infections can be treated with medication, but sometimes they come back after treatment. Researchers want to know if using vaginal suppositories can decrease the risk of vaginal infections. Participants will include 234 women who are sexually active (greater than or equal to 4 episodes of sex with men during the past month), HIV-negative, 18 to 45 years old, with bacterial infection [vaginosis and/or vulvovaginal candidiasis (VVC) and/or Trichomonas vaginalis] detected by laboratory testing at a screening visit. Women will receive vaginal suppositories containing drug or inactive ingredients (placebo). Participation in the study will be about 12 months. Study procedures include: urine and blood tests, physical exams, and questionnaires.

NCT ID: NCT01226433 Completed - Clinical trials for The Study Goal is to Assess the Introduction of Sustainable Family Planning/Reproductive Health Information and Services Through

Family Planning Through Dairy Cooperatives

Start date: October 2010
Phase: N/A
Study type: Observational

This observational study will assess a model for providing family planning through quarterly events organized by dairy cooperatives supported by Land O'Lakes in Kenya.